Compounds > sudan black b
Page last updated: 2024-09-23

sudan black b

Description

Sudan black B : A member of the class of perimidines that is 2,2-dimethyl-2,3-dihydro-1H-perimidine carrying a [4-(phenyldiazenyl)naphthalen-1-yl]diazenyl substituent at position 6. A fat-soluble dye predominantly used for demonstrating triglycerides in frozen sections and for staining of protein bound lipids in paraffin sections. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID61336
CHEMBL ID1872445
CHEBI ID88216
SCHEMBL ID136569
SCHEMBL ID15497822
MeSH IDM0065884

Synonyms (80)

Synonym
fat black hb 01
ci 26150
2,3-dihydro-2,2-dimethyl-6-((1-naphthyl-4-(phenylazo))azo)-1h-perimidine
2,3-dihydro-2,2-dimethyl-6-((4-(phenylazo)-1-naphthalenyl)azo)-1h- -pyrimidine
sot-black 6
einecs 224-087-1
1h-perimidine, 2,3-dihydro-2,2-dimethyl-6-((4-(phenylazo)-1-naphthyl)azo)-
aizen sot black 6
1h-perimidine, 2,3-dihydro-2,2-dimethyl-6-((4-(phenylazo)-1-naphthalenyl)azo)-
ai3-51681
brn 0723248
2,3-dihydro-2,2-dimethyl-6-((4-(phenylazo)-1-naphthyl)azo)perimidine
1h-pyrimidine, 2,3-dihydro-2,2-dimethyl-6-((4-(phenylazo)-1-naphthalenyl)azo)-
nsc 11239
neptune black x 60
solvent black 3
sudan black x 60
c.i. solvent black 3
sudan deep black bn
nubian black bt
fast black hb
nsc11239
lacquer black s
typogen black
ceres black bn
lacquer black vb
4197-25-5
hexatype black b
sudan black b
fat black hb
nsc-11239
c.i. 26150
1h-perimidine,3-dihydro-2,2-dimethyl-6-[[4-(phenylazo)-1-naphthalenyl]azo]-
1h-perimidine,3-dihydro-2,2-dimethyl-6-[[4-(phenylazo)-1-naphthyl]azo]-
fast black hbn
2,2-dimethyl-6-[[4-(phenylazo)-1-naphthyl]azo]perimidine
sudan deep black bb
2,3-dihydro-2,2-dimethyl-6-[[4-(phenylazo)-1-naphthyl]azo]perimidine
(e)-(2,2-dimethyl-1,3-dihydroperimidin-6-yl)-[4-[(z)-phenylazo]-1-naphthyl]diazene
SSB ,
sudan black b, certified by the biological stain commission
STL069552
2,2-dimethyl-6-[(e)-{4-[(e)-phenyldiazenyl]naphthalen-1-yl}diazenyl]-2,3-dihydro-1h-perimidine
(2,2-dimethyl-1,3-dihydroperimidin-6-yl)-(4-phenyldiazenylnaphthalen-1-yl)diazene
AKOS005111373
S0113
AKOS004910350
NCGC00187595-01
sudan black
1h-perimidine, 2,3-dihydro-2,2-dimethyl-6-(2-(4-(2-phenyldiazenyl)-1-naphthalenyl)diazenyl)-
9ydl1q990e ,
unii-9ydl1q990e
FT-0682677
solvent black 3 [inci]
ssb-ii
2,3-dihydro-2,2-dimethyl-6-((4-(phenylazo)-1-naphthalenyl)azo)-1h-perimidine
sbb-ii
sudan black b [mi]
2,2-dimethyl-6-{[4-(phenyldiazenyl)-1-naphthyl]-diazenyl}-2,3-dihydro-1h-perimidine
SCHEMBL136569
DTXSID0052091
SCHEMBL15497822
YCUVUDODLRLVIC-VPHDGDOJSA-N
1h-perimidine, 2,3-dihydro-2,2-dimethyl-6-[[4-(phenylazo)-1-naphthalenyl]azo]-
2,2-dimethyl-6-((4-(phenyldiazenyl)-1-naphthyl)diazenyl)-2,3-dihydro-1h-perimidine #
Q-201755
CHEMBL1872445
2,3-dihydro-2,2-dimethyl-6-((4-(phenylazo)-1-naphthalenyl)azo)-1h-pyrimidine
CHEBI:88216
2,2-dimethyl-6-{[4-(phenyldiazenyl)naphthalen-1-yl]diazenyl}-2,3-dihydro-1h-perimidine
AKOS025116955
mfcd00006919
2,2-dimethyl-6-((e)-(4-((e)-phenyldiazenyl)naphthalen-1-yl)diazenyl)-2,3-dihydro-1h-perimidine
2,2-dimethyl-6-((4-(phenyldiazenyl)naphthalen-1-yl)diazenyl)-2,3-dihydro-1h-perimidine
Q10861380
AMY22420
D92231
HY-D0213
CS-0010125
sudanblack

Research Excerpts

Overview

ExcerptReference
"Sudan black B (SBB) is a staining dye widely used in histological studies to eliminate autofluorescence."( Chen, X; Fan, X; Jiang, C; Li, C; Niu, X; Peng, Q; Ren, X; Song, C; Wang, J; Wang, S; Zang, W; Zille, M, 2023)
"Sudan Black B (SB) is a lysochrome dye commonly used to stain lipids in histology."( Goh, JC; Neo, PY; Shi, P; Tan, DJ; Toh, SL, 2015)

Effects

ExcerptReference
"Sudan Black B dye has been commonly used to quench autofluorescence, but can also introduce background fluorescence."( Whittington, NC; Wray, S, 2017)

Roles (1)

RoleDescription
histological dyeA dye used in microscopic or electron microscopic examination of cells and tissues to give contrast and to highlight particular features of interest, such as nuclei and cytoplasm.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
azobenzenesAny member of the wide class of molecules that share the core azobenzene structure, comprising two phenyl rings linked by a N=N double bond, which may have different functional groups extending from the rings.
bis(azo) compoundAny azo compound containing two -N=N- groups.
perimidines
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency15.58640.000811.382244.6684AID686978; AID686979
eyes absent homolog 2 isoform aHomo sapiens (human)Potency3.01361.199814.641950.1187AID720540
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency89.12510.050127.073689.1251AID588590
Alpha-synucleinHomo sapiens (human)Potency12.58930.56239.398525.1189AID652106
C-terminal-binding protein 1Homo sapiens (human)Potency3.38140.30149.321019.0148AID720541
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (86)

Processvia Protein(s)Taxonomy
calcium ion homeostasisAlpha-synucleinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIAlpha-synucleinHomo sapiens (human)
microglial cell activationAlpha-synucleinHomo sapiens (human)
positive regulation of receptor recyclingAlpha-synucleinHomo sapiens (human)
positive regulation of neurotransmitter secretionAlpha-synucleinHomo sapiens (human)
negative regulation of protein kinase activityAlpha-synucleinHomo sapiens (human)
fatty acid metabolic processAlpha-synucleinHomo sapiens (human)
neutral lipid metabolic processAlpha-synucleinHomo sapiens (human)
phospholipid metabolic processAlpha-synucleinHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
mitochondrial membrane organizationAlpha-synucleinHomo sapiens (human)
adult locomotory behaviorAlpha-synucleinHomo sapiens (human)
response to xenobiotic stimulusAlpha-synucleinHomo sapiens (human)
response to iron(II) ionAlpha-synucleinHomo sapiens (human)
regulation of phospholipase activityAlpha-synucleinHomo sapiens (human)
negative regulation of platelet-derived growth factor receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
regulation of glutamate secretionAlpha-synucleinHomo sapiens (human)
regulation of dopamine secretionAlpha-synucleinHomo sapiens (human)
synaptic vesicle exocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle primingAlpha-synucleinHomo sapiens (human)
regulation of transmembrane transporter activityAlpha-synucleinHomo sapiens (human)
negative regulation of microtubule polymerizationAlpha-synucleinHomo sapiens (human)
receptor internalizationAlpha-synucleinHomo sapiens (human)
protein destabilizationAlpha-synucleinHomo sapiens (human)
response to magnesium ionAlpha-synucleinHomo sapiens (human)
negative regulation of transporter activityAlpha-synucleinHomo sapiens (human)
response to lipopolysaccharideAlpha-synucleinHomo sapiens (human)
negative regulation of monooxygenase activityAlpha-synucleinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAlpha-synucleinHomo sapiens (human)
response to type II interferonAlpha-synucleinHomo sapiens (human)
cellular response to oxidative stressAlpha-synucleinHomo sapiens (human)
SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
positive regulation of SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
regulation of locomotionAlpha-synucleinHomo sapiens (human)
dopamine biosynthetic processAlpha-synucleinHomo sapiens (human)
mitochondrial ATP synthesis coupled electron transportAlpha-synucleinHomo sapiens (human)
regulation of macrophage activationAlpha-synucleinHomo sapiens (human)
positive regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of neuron apoptotic processAlpha-synucleinHomo sapiens (human)
positive regulation of endocytosisAlpha-synucleinHomo sapiens (human)
negative regulation of exocytosisAlpha-synucleinHomo sapiens (human)
positive regulation of exocytosisAlpha-synucleinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAlpha-synucleinHomo sapiens (human)
synaptic vesicle endocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle transportAlpha-synucleinHomo sapiens (human)
positive regulation of inflammatory responseAlpha-synucleinHomo sapiens (human)
regulation of acyl-CoA biosynthetic processAlpha-synucleinHomo sapiens (human)
protein tetramerizationAlpha-synucleinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolAlpha-synucleinHomo sapiens (human)
neuron apoptotic processAlpha-synucleinHomo sapiens (human)
dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of serotonin uptakeAlpha-synucleinHomo sapiens (human)
regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
negative regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
excitatory postsynaptic potentialAlpha-synucleinHomo sapiens (human)
long-term synaptic potentiationAlpha-synucleinHomo sapiens (human)
positive regulation of inositol phosphate biosynthetic processAlpha-synucleinHomo sapiens (human)
negative regulation of thrombin-activated receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
response to interleukin-1Alpha-synucleinHomo sapiens (human)
cellular response to copper ionAlpha-synucleinHomo sapiens (human)
cellular response to epinephrine stimulusAlpha-synucleinHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityAlpha-synucleinHomo sapiens (human)
supramolecular fiber organizationAlpha-synucleinHomo sapiens (human)
negative regulation of mitochondrial electron transport, NADH to ubiquinoneAlpha-synucleinHomo sapiens (human)
positive regulation of glutathione peroxidase activityAlpha-synucleinHomo sapiens (human)
positive regulation of hydrogen peroxide catabolic processAlpha-synucleinHomo sapiens (human)
regulation of synaptic vesicle recyclingAlpha-synucleinHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processAlpha-synucleinHomo sapiens (human)
positive regulation of protein localization to cell peripheryAlpha-synucleinHomo sapiens (human)
negative regulation of chaperone-mediated autophagyAlpha-synucleinHomo sapiens (human)
regulation of presynapse assemblyAlpha-synucleinHomo sapiens (human)
amyloid fibril formationAlpha-synucleinHomo sapiens (human)
synapse organizationAlpha-synucleinHomo sapiens (human)
chemical synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIC-terminal-binding protein 1Homo sapiens (human)
protein phosphorylationC-terminal-binding protein 1Homo sapiens (human)
negative regulation of cell population proliferationC-terminal-binding protein 1Homo sapiens (human)
viral genome replicationC-terminal-binding protein 1Homo sapiens (human)
negative regulation of DNA-templated transcriptionC-terminal-binding protein 1Homo sapiens (human)
positive regulation of DNA-templated transcriptionC-terminal-binding protein 1Homo sapiens (human)
synaptic vesicle endocytosisC-terminal-binding protein 1Homo sapiens (human)
white fat cell differentiationC-terminal-binding protein 1Homo sapiens (human)
regulation of cell cycleC-terminal-binding protein 1Homo sapiens (human)
synaptic vesicle clusteringC-terminal-binding protein 1Homo sapiens (human)
regulation of transcription by RNA polymerase IIC-terminal-binding protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (36)

Processvia Protein(s)Taxonomy
fatty acid bindingAlpha-synucleinHomo sapiens (human)
phospholipase D inhibitor activityAlpha-synucleinHomo sapiens (human)
SNARE bindingAlpha-synucleinHomo sapiens (human)
magnesium ion bindingAlpha-synucleinHomo sapiens (human)
transcription cis-regulatory region bindingAlpha-synucleinHomo sapiens (human)
actin bindingAlpha-synucleinHomo sapiens (human)
protein kinase inhibitor activityAlpha-synucleinHomo sapiens (human)
copper ion bindingAlpha-synucleinHomo sapiens (human)
calcium ion bindingAlpha-synucleinHomo sapiens (human)
protein bindingAlpha-synucleinHomo sapiens (human)
phospholipid bindingAlpha-synucleinHomo sapiens (human)
ferrous iron bindingAlpha-synucleinHomo sapiens (human)
zinc ion bindingAlpha-synucleinHomo sapiens (human)
lipid bindingAlpha-synucleinHomo sapiens (human)
oxidoreductase activityAlpha-synucleinHomo sapiens (human)
kinesin bindingAlpha-synucleinHomo sapiens (human)
Hsp70 protein bindingAlpha-synucleinHomo sapiens (human)
histone bindingAlpha-synucleinHomo sapiens (human)
identical protein bindingAlpha-synucleinHomo sapiens (human)
alpha-tubulin bindingAlpha-synucleinHomo sapiens (human)
cysteine-type endopeptidase inhibitor activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
tau protein bindingAlpha-synucleinHomo sapiens (human)
phosphoprotein bindingAlpha-synucleinHomo sapiens (human)
molecular adaptor activityAlpha-synucleinHomo sapiens (human)
dynein complex bindingAlpha-synucleinHomo sapiens (human)
cuprous ion bindingAlpha-synucleinHomo sapiens (human)
transcription corepressor bindingC-terminal-binding protein 1Homo sapiens (human)
chromatin bindingC-terminal-binding protein 1Homo sapiens (human)
transcription corepressor activityC-terminal-binding protein 1Homo sapiens (human)
protein bindingC-terminal-binding protein 1Homo sapiens (human)
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptorC-terminal-binding protein 1Homo sapiens (human)
protein domain specific bindingC-terminal-binding protein 1Homo sapiens (human)
identical protein bindingC-terminal-binding protein 1Homo sapiens (human)
NAD bindingC-terminal-binding protein 1Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingC-terminal-binding protein 1Homo sapiens (human)
DNA-binding transcription factor bindingC-terminal-binding protein 1Homo sapiens (human)
transcription coactivator activityC-terminal-binding protein 1Homo sapiens (human)
transcription coregulator bindingC-terminal-binding protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (27)

Processvia Protein(s)Taxonomy
platelet alpha granule membraneAlpha-synucleinHomo sapiens (human)
extracellular regionAlpha-synucleinHomo sapiens (human)
extracellular spaceAlpha-synucleinHomo sapiens (human)
nucleusAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
mitochondrionAlpha-synucleinHomo sapiens (human)
lysosomeAlpha-synucleinHomo sapiens (human)
cytosolAlpha-synucleinHomo sapiens (human)
plasma membraneAlpha-synucleinHomo sapiens (human)
cell cortexAlpha-synucleinHomo sapiens (human)
actin cytoskeletonAlpha-synucleinHomo sapiens (human)
membraneAlpha-synucleinHomo sapiens (human)
inclusion bodyAlpha-synucleinHomo sapiens (human)
axonAlpha-synucleinHomo sapiens (human)
growth coneAlpha-synucleinHomo sapiens (human)
synaptic vesicle membraneAlpha-synucleinHomo sapiens (human)
perinuclear region of cytoplasmAlpha-synucleinHomo sapiens (human)
postsynapseAlpha-synucleinHomo sapiens (human)
supramolecular fiberAlpha-synucleinHomo sapiens (human)
protein-containing complexAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
axon terminusAlpha-synucleinHomo sapiens (human)
neuronal cell bodyAlpha-synucleinHomo sapiens (human)
nucleusC-terminal-binding protein 1Homo sapiens (human)
nucleoplasmC-terminal-binding protein 1Homo sapiens (human)
presynaptic active zone cytoplasmic componentC-terminal-binding protein 1Homo sapiens (human)
glutamatergic synapseC-terminal-binding protein 1Homo sapiens (human)
GABA-ergic synapseC-terminal-binding protein 1Homo sapiens (human)
transcription repressor complexC-terminal-binding protein 1Homo sapiens (human)
nucleusC-terminal-binding protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (206)

TimeframeStudies, This Drug (%)All Drugs %
pre-199086 (41.75)18.7374
1990's31 (15.05)18.2507
2000's38 (18.45)29.6817
2010's43 (20.87)24.3611
2020's8 (3.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.90%)5.53%
Reviews5 (2.25%)6.00%
Case Studies14 (6.31%)4.05%
Observational0 (0.00%)0.25%
Other201 (90.54%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
fluorescein-5-isothiocyanate[no description available]medium20fluorescein isothiocyanate
formaldehyde[no description available]medium80aldehyde;
one-carbon compound		allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
sodium borohydride[no description available]medium10inorganic sodium salt;
metal tetrahydridoborate
titanium[no description available]medium21titanium group element atom
titanium dioxide[no description available]medium10titanium oxidesfood colouring
ninhydrin[no description available]medium10aromatic ketone;
beta-diketone;
indanones;
ketone hydrate		colour indicator;
human metabolite
1-(2-pyridylazo)-2-naphthol[no description available]medium10
2-naphthol[no description available]medium50naphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
hydronium ion[no description available]medium10onium cation;
oxygen hydride
hydroxide ion[no description available]medium10oxygen hydridemouse metabolite
glycerol[no description available]medium20alditol;
triol		algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
acid phosphatase[no description available]medium100
nile blue[no description available]medium40
lipoamide[no description available]medium10dithiolanes;
monocarboxylic acid amide		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1-anilino-8-naphthalenesulfonate[no description available]medium20aminonaphthalene;
naphthalenesulfonic acid		fluorescent probe
2-methylpentane[no description available]medium10alkane
n-hexane[no description available]medium10alkane;
volatile organic compound		neurotoxin;
non-polar solvent
lysophosphatidylcholines[no description available]medium101-O-acyl-sn-glycero-3-phosphocholine
phosphatidylcholines[no description available]medium101,2-diacyl-sn-glycero-3-phosphocholine
acridine orange[no description available]medium10aminoacridines;
aromatic amine;
tertiary amino compound		fluorochrome;
histological dye
delphinidin[no description available]medium10anthocyanidin chloride
ethenzamide[no description available]medium10organic molecular entity
acetaminophen[no description available]medium10acetamides;
phenols		antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
stearic acid[no description available]medium10long-chain fatty acid;
saturated fatty acid;
straight-chain saturated fatty acid		algal metabolite;
Daphnia magna metabolite;
human metabolite;
plant metabolite
sudan iii[no description available]high30azobenzenes;
bis(azo) compound;
naphthols		carcinogenic agent;
fluorochrome;
histological dye
scarlet red[no description available]high30azobenzenes;
bis(azo) compound;
naphthols		carcinogenic agent;
fluorochrome;
histological dye
sudan red[no description available]medium30
1-phenylazo-2-naphthol[no description available]medium10
biotin[no description available]medium10biotins;
vitamin B7		coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite
mocetinostat[no description available]medium240aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline		antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
filipin[no description available]medium10
trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride[no description available]medium10
hoe 33342[no description available]medium20
sodium hypochlorite[no description available]medium11inorganic sodium saltbleaching agent;
disinfectant
nickel[no description available]medium11metal allergen;
nickel group element atom		epitope;
micronutrient
eosine yellowish-(ys)[no description available]medium30organic sodium salt;
organobromine compound		fluorochrome;
histological dye
methylene blue[no description available]medium30organic chloride saltacid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer
nile red[no description available]medium10aromatic amine;
cyclic ketone;
organic heterotetracyclic compound;
tertiary amino compound		fluorochrome;
histological dye
ammonium hydroxide[no description available]medium30azane;
gas molecular entity;
mononuclear parent hydride		EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
tretinoin[no description available]medium10retinoic acid;
vitamin A		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
lg 100268[no description available]medium10
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid[no description available]medium10benzoic acids;
naphthalenes;
retinoid		antineoplastic agent;
retinoic acid receptor agonist;
teratogenic agent
lactic acid[no description available]medium202-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
myelin basic protein[no description available]medium40
3,3'-dioctadecylindocarbocyanine[no description available]medium10Cy5 dye;
indolium ion		fluorochrome
carbocyanines[no description available]medium10cyanine dye;
organic iodide salt		fluorochrome
colforsin[no description available]medium10acetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol		adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist
osmium tetroxide[no description available]medium20osmium coordination entityfixative;
histological dye;
oxidising agent;
poison
carmine[no description available]medium10
phenol[no description available]medium10phenolsantiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite
phenyl acetate[no description available]medium20benzenes;
phenyl acetates
ethyl acetate[no description available]medium10acetate ester;
ethyl ester;
volatile organic compound		EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor;
metabolite;
polar aprotic solvent;
Saccharomyces cerevisiae metabolite
propylene glycol[no description available]medium10glycol;
propane-1,2-diols		allergen;
human xenobiotic metabolite;
mouse metabolite;
protic solvent
1,4-dioxane[no description available]medium10dioxane;
volatile organic compound		carcinogenic agent;
metabolite;
NMR chemical shift reference compound;
non-polar solvent
ethylene glycol[no description available]medium20ethanediol;
glycol		metabolite;
mouse metabolite;
solvent;
toxin
hematoxylin[no description available]medium20organic heterotetracyclic compound;
oxacycle;
polyphenol;
tertiary alcohol		histological dye;
plant metabolite
molybdenum[no description available]medium10chromium group element atommicronutrient
tolonium chloride[no description available]medium30
propylene[no description available]medium10alkene;
gas molecular entity		refrigerant;
xenobiotic
alkenes[no description available]medium10
alcian blue[no description available]medium10
3-hydroxybutyric acid[no description available]medium10(omega-1)-hydroxy fatty acid;
3-hydroxy monocarboxylic acid;
hydroxybutyric acid		human metabolite
metaperiodate[no description available]medium20iodine oxoacid
glycogen[no description available]medium20
arachidonic acid[no description available]medium10icosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid		Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
dapi[no description available]medium20indolesfluorochrome
fibrin[no description available]medium10peptide
sincalide[no description available]medium10oligopeptide
sodium tetraethylborate[no description available]medium10
congo red[no description available]medium20bis(azo) compound
1,9-dimethylmethylene blue[no description available]medium10
adenosine-5'-(n-ethylcarboxamide)[no description available]medium10adenosines;
monocarboxylic acid amide		adenosine A1 receptor agonist;
adenosine A2A receptor agonist;
antineoplastic agent;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
adenosine[no description available]medium10adenosines;
purines D-ribonucleoside		analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
tetrodotoxin[no description available]medium10azatetracycloalkane;
oxatetracycloalkane;
quinazoline alkaloid		animal metabolite;
bacterial metabolite;
marine metabolite;
neurotoxin;
voltage-gated sodium channel blocker
2-methylthio-atp[no description available]medium10
aluminum[no description available]medium10boron group element atom;
elemental aluminium;
metal atom
sybr green i[no description available]medium10benzothiazolium ion;
cyanine dye;
quinolines;
tertiary amine		fluorescent dye
c.i. 42510[no description available]medium30
coomassie brilliant blue[no description available]medium10
3,3'-diaminobenzidine[no description available]medium10biphenyls;
substituted aniline		histological dye
sepharose[no description available]medium10
nitroblue tetrazolium[no description available]medium20organic cation
sodium fluoride[no description available]medium10fluoride saltmutagen
nitrous oxide[no description available]medium10gas molecular entity;
nitrogen oxide		analgesic;
bacterial metabolite;
food packaging gas;
food propellant;
general anaesthetic;
greenhouse gas;
inhalation anaesthetic;
NMDA receptor antagonist;
raising agent;
refrigerant;
vasodilator agent
aminosalicylic acid[no description available]medium10aminobenzoic acid;
phenols		antitubercular agent
mercaptopurine[no description available]medium10aryl thiol;
purines;
thiocarbonyl compound		anticoronaviral agent;
antimetabolite;
antineoplastic agent
prednisolone[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
daunorubicin[no description available]medium10aminoglycoside antibiotic;
anthracycline;
p-quinones;
tetracenequinones		antineoplastic agent;
bacterial metabolite
cytarabine[no description available]medium10beta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside		antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
cyclosporine[no description available]medium10
choline[no description available]medium10cholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
transforming growth factor beta[no description available]medium10
succinoglycan[no description available]medium10
tacrolimus[no description available]medium10macrolide lactambacterial metabolite;
immunosuppressive agent
copper sulfate[no description available]medium10metal sulfateemetic;
fertilizer;
sensitiser
toluene 2,4-diisocyanate[no description available]medium10toluene meta-diisocyanateallergen;
hapten
malachite green[no description available]medium10organic chloride saltantibacterial agent;
antifungal drug;
carcinogenic agent;
environmental contaminant;
fluorochrome;
histological dye;
teratogenic agent
ng-nitroarginine methyl ester[no description available]medium10alpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor
hydralazine[no description available]medium10azaarene;
hydrazines;
ortho-fused heteroarene;
phthalazines		antihypertensive agent;
vasodilator agent
cytochalasin d[no description available]medium10
linoleic acid[no description available]medium10octadecadienoic acid;
omega-6 fatty acid		algal metabolite;
Daphnia galeata metabolite;
plant metabolite
propidium[no description available]medium10phenanthridines;
quaternary ammonium ion		fluorochrome;
intercalator
chondroitin sulfates[no description available]medium10
paraquat[no description available]medium10organic cationgeroprotector;
herbicide
hydroxyethyl methacrylate[no description available]medium10enoate esterallergen;
polymerisation monomer
cresyl violet[no description available]medium10
thionine[no description available]medium10
silver[no description available]medium10copper group element atom;
elemental silver		Escherichia coli metabolite
gentamicin[no description available]medium10
valproic acid[no description available]medium10branched-chain fatty acid;
branched-chain saturated fatty acid		anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
naphthol as-d chloroacetate[no description available]medium10
muramidase[no description available]medium10
losartan potassium[no description available]medium10
strontium[no description available]medium10alkaline earth metal atom
carbonates[no description available]medium10carbon oxoanion
fat red 7b[no description available]medium10
aurintricarboxylic acid[no description available]low00monohydroxybenzoic acid;
quinomethanes;
tricarboxylic acid		fluorochrome;
histological dye;
insulin-like growth factor receptor 1 antagonist
purpurin[no description available]low00trihydroxyanthraquinonebiological pigment;
histological dye;
plant metabolite
rhodamine b[no description available]low00organic chloride salt;
xanthene dye		fluorescent probe;
fluorochrome;
histological dye
acriflavine chloride[no description available]low00organic chloride saltantibacterial agent;
antiseptic drug;
carcinogenic agent;
histological dye;
intercalator
pyronine[no description available]low00iminium salt;
organic chloride salt		histological dye
evans blue[no description available]low00organic sodium saltfluorochrome;
histological dye;
sodium channel blocker;
teratogenic agent
naphthol yellow[no description available]low00C-nitro compound;
naphthalenesulfonic acid;
naphthols		histological dye
gentian violet[no description available]low00organic chloride saltanthelminthic drug;
antibacterial agent;
antifungal agent;
antiseptic drug;
histological dye
brilliant green[no description available]low00organic hydrogensulfate saltantibacterial agent;
antiseptic drug;
environmental contaminant;
fluorochrome;
histological dye;
poison
pyronine b[no description available]low00iminium salt;
organic chloride salt		histological dye
basic blue k[no description available]low00iminium salt;
organic chloride salt		fluorochrome;
histological dye
fast green fcf[no description available]low00organic sodium saltfluorochrome;
food colouring;
histological dye
thioflavin t[no description available]low00organic chloride saltfluorochrome;
geroprotector;
histological dye
ethyl violet[no description available]low00organic chloride saltfluorochrome;
histological dye
benzophenoneidum[no description available]low00hydrochloridefluorochrome;
histological dye
victoria blue b[no description available]low00iminium salt;
organic chloride salt		fluorochrome;
histological dye
red 2g[no description available]low00organic sodium salthistological dye
biebrich scarlet[no description available]low00organic sodium salthistological dye
chromotrope 2r[no description available]low00organic sodium salthistological dye
light green sf[no description available]low00organic sodium salthistological dye
brilliant crocein[no description available]low00organic sodium salthistological dye
iodonitrotetrazolium[no description available]low00organic chloride salthistological dye
phenosafranine[no description available]low00organic chloride saltfluorochrome;
histological dye;
photosensitizing agent
fast blue b[no description available]low00aromatic diazonium ionhistological dye
brazilin[no description available]low00catechols;
organic heterotetracyclic compound;
tertiary alcohol		anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
biological pigment;
hepatoprotective agent;
histological dye;
NF-kappaB inhibitor;
plant metabolite
gallein[no description available]low002-benzofurans;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
polyphenol;
xanthene dye		fluorochrome;
G-protein-coupled receptor antagonist;
histological dye
c.i. direct red 80[no description available]low00organic sodium saltfluorochrome;
histological dye
methylene green[no description available]low00organic chloride saltfluorochrome;
histological dye
victoria blue 4r[no description available]low00iminium salt;
organic chloride salt		fluorochrome;
histological dye
safranine t[no description available]low00organic chloride saltfluorochrome;
histological dye
ponceau s[no description available]low00organic sodium salt;
organosulfonate salt		fluorochrome;
histological dye
primuline[no description available]low00organic sodium salt;
organosulfonate salt		fluorochrome;
histological dye
metanil yellow[no description available]low00organic sodium salthistological dye
alizarin red s[no description available]low00organic sodium salt;
organosulfonate salt		histological dye
gardenia yellow[no description available]low00diester;
disaccharide derivative;
diterpenoid		antioxidant;
food colouring;
histological dye;
plant metabolite
lissamine rhodamine b[no description available]low00organic sodium saltfluorescent probe;
fluorochrome;
histological dye
carmine[no description available]low00C-glycosyl compound;
monocarboxylic acid;
tetrahydroxyanthraquinone		animal metabolite;
histological dye
eosine i bluish[no description available]low00organic sodium saltfluorescent dye;
histological dye
new fuchsin[no description available]low00hydrochloridefluorochrome;
histological dye
azocarmine g[no description available]low00organic sodium salthistological dye
nuclear fast red[no description available]low00organic sodium saltfluorochrome;
histological dye
alcian yellow[no description available]low00iminium salt;
organic chloride salt		fluorochrome;
histological dye
azobenzene[no description available]low00azobenzenes
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid[no description available]low00arenesulfonic acid;
azobenzenes;
methylpyridines;
monohydroxypyridine;
organic phosphate;
pyridinecarbaldehyde		purinergic receptor P2X antagonist
p-dimethylaminoazobenzene[no description available]low00azobenzenes
disperse orange 3[no description available]low00azobenzenes;
primary arylamine		allergen;
dye
ethoxazene[no description available]low00azobenzenes
c.i. solvent yellow 56[no description available]low00azobenzenes;
substituted aniline;
tertiary amino compound		dye;
mutagen
olsalazine[no description available]low00azobenzenes;
dicarboxylic acid		non-steroidal anti-inflammatory drug;
prodrug
reactive red 120 dye[no description available]low00azobenzenes;
bis(azo) compound;
chloro-1,3,5-triazine;
diamino-1,3,5-triazine;
naphthalenesulfonic acid		dye
ponceau mx[no description available]low00azobenzenes;
naphthalenesulfonic acid;
naphthols		carcinogenic agent;
cardiotoxic agent
bis-q[no description available]low00azobenzenes
butanoic acid [2-oxo-2-(4-phenyldiazenylanilino)ethyl] ester[no description available]low00azobenzenes
2-[4-(dimethylamino)phenyl]azobenzoic acid [2-(1-azepanyl)-2-oxoethyl] ester[no description available]low00azobenzenes
ConditionIndicatedRelationship StrengthStudiesTrials
A-alphalipoprotein Neuropathy0low10
Abetalipoproteinemia0low10
Acanthocytosis0low10
Actinobacillus Infections0low10
Acute Biphenotypic Leukemia0low10
Acute Brain Injuries0low10
Acute Disease0medium71
Acute Ischemic Stroke0low10
Acute Lymphoid Leukemia0low40
Acute Myelogenous Leukemia0low120
Acute Myeloid Leukemia0low120
Acute Myeloid Leukemia with Maturation0low120
Acute Myeloid Leukemia without Maturation0low120
Acute Promyelocytic Leukemia0low30
Adenoma0low10
Adenoma, Basal Cell0low10
Adenoma, Follicular0low10
Adenoma, Microcystic0low10
Adenoma, Monomorphic0low10
Adenoma, Papillary0low10
Adenoma, Trabecular0low10
Aging0low100
Albinism0low10
ALL, Childhood0low40
Alpha High Density Lipoprotein Deficiency Disease0low10
AML M30low30
Analphalipoproteinemia0low10
ANLL0low120
Anterior Circulation Transient Ischemic Attack0low10
Arteriosclerosis0low20
Arthritis, Rheumatoid0low10
Atypical Lipomatous Tumor0low10
B and T Cell Acute Lymphoblastic Leukemia0low10
B and T Cell Leukemia, Acute0low10
B- and T-Cell Acute Lymphoblastic Leukemia0low10
B- and T-Cell Leukemia, Acute0low10
Bare Lymphocyte Syndrome0low10
Bassen-Kornzweig Disease0low10
Bassen-Kornzweig Syndrome0low10
Benign Neoplasms0low10
Berylliosis0low10
Beryllium Disease0low10
Betalipoprotein Deficiency Disease0low10
Bile Duct Obstruction0low10
Biliary Stasis0low10
Biphenotypic Acute Leukemia0low10
Blastocyst Disintegration0low10
Blood Pressure, High0low10
Brain Hemorrhage, Cerebral0low10
Brain Injuries0low10
Brain Injuries, Acute0low10
Brain Injuries, Focal0low10
Brain Injuries, Traumatic0low10
Brain Lacerations0low10
Brain Stem Ischemia, Transient0low10
Brain Stem Transient Ischemic Attack0low10
Brain TIA0low10
Brainstem Ischemia, Transient0low10
Brainstem Transient Ischemic Attack0low10
Calcification, Pathologic0low10
Calcinosis0low10
Calcinosis, Tumoral0low10
Cancer0low10
Cancer of Larynx0low10
Cancer of the Larynx0low10
Cancer, Second Primary0low10
Candida Infection0low10
Candidiasis0low10
Canine Diseases0low10
Cardiovascular Stroke0low10
Carotid Circulation Transient Ischemic Attack0low10
Cell Transformation, Neoplastic0low10
Cerebral Hemorrhage0low10
Cerebral Ischemia, Transient0low10
Cerebral Parenchymal Hemorrhage0low10
Chediak-Higashi Syndrome0low10
Chediak-Steinbrinck-Higashi Syndrome0low10
Cholestasis0low10
Cholesterol Thesaurismosis0low10
Chondroma0low10
Chronic Disease0low10
Chronic Illness0low10
Chronically Ill0low10
Clinically Isolated CNS Demyelinating Syndrome0low20
Clinically Isolated Syndrome, CNS Demyelinating0low20
Crescendo Transient Ischemic Attacks0low10
Cryptogenic Embolism Stroke0low10
Cryptogenic Ischemic Stroke0low10
Cryptogenic Stroke0low10
Degenerative Disc Disease0low10
Degenerative Intervertebral Discs0low10
Degenerative Intervertebral Disks0low10
Demyelinating Diseases0low20
Demyelinating Disorders0low20
Demyelination0low20
Dentigerous Cyst0low10
Diathesis0low10
Disc Degeneration0low10
Disc Degradation0low10
Disease Models, Animal0low10
Disease Susceptibility0low10
Disease, Pulmonary0low10
Diseases, Pulmonary0low10
Disintegration of Blastocyst0low10
Disintegration of Embryo0low10
Disk Degeneration0low10
Disk Degradation0low10
Dog Diseases0low10
Drusen, Retinal0low10
Ectopic Ossification0low10
Electrolytes0low10
Embryo Death0low10
Embryo Disintegration0low10
Embryo Loss0low10
Embryo Resorption0low10
Encephalopathy, Traumatic0low10
Enchondroma0low10
Experimental Neoplasms0low10
Focal Brain Injuries0low10
Germinoblastoma0low10
Glial Cell Tumors0low20
Glioma0low20
Granulocytic Leukemia0medium41
Granulocytic Leukemia, Chronic0low10
HDLDT10low10
Heart Attack0low10
Hemorrhage, Cerebral0low10
Hemorrhage, Cerebrum0low10
Hemorrhagic Stroke0low10
Heterotopic Ossification0low10
High Density Lipoprotein Deficiency, Tangier Type0low10
High Density Lipoprotein Deficiency, Type 10low10
High-Density Lipoprotein Deficiency, Tangier Type0low10
High-Density Lipoprotein Deficiency, Type I0low10
Hybrid Acute Leukemias0low10
Hypertension0low10
Immunodeficiency Syndrome, Severe Combined0low10
Immunodeficiency, Severe Combined0low10
Immunologic Deficiency, Severe Combined0low10
Infections, Actinobacillus0low10
Infections, Taenia0low10
Inflammation0low10
Injuries, Acute Brain0low10
Injuries, Brain0low10
Injury, Brain, Traumatic0low10
Innate Inflammatory Response0low10
Intervertebral Disc Degeneration0low10
Intervertebral Disk Degeneration0low10
Intracerebral Hemorrhage0low10
Intracerebral Hemorrhage Stroke0low10
Intracerebral Hemorrhagic Stroke0low10
Ischaemic Stroke0low10
Ischemic Attack, Transient0low10
Ischemic Stroke0low10
Keratocysts0low10
Kidney Diseases0low10
Laryngeal Cancer0low10
Laryngeal Neoplasms0low10
Larynx Cancer0low10
Larynx Neoplasms0low10
Leucocythaemia0low80
Leucocythemia0low80
Leukemia0low80
Leukemia, Acute Lymphoblastic0low40
Leukemia, Acute Myelogenous0low120
Leukemia, Acute Myeloid0low120
Leukemia, Acute Promyelocytic0low30
Leukemia, Biphenotypic, Acute0low10
Leukemia, Chronic Myelogenous0low10
Leukemia, Chronic Myeloid0low10
Leukemia, Granulocytic0medium41
Leukemia, Granulocytic, Chronic0low10
Leukemia, Lymphoblastic0low40
Leukemia, Lymphoblastic, Acute0low40
Leukemia, Lymphoblastic, Acute, L10low40
Leukemia, Lymphoblastic, Acute, L20low40
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive0low40
Leukemia, Lymphocytic0low70
Leukemia, Lymphocytic, Acute0low40
Leukemia, Lymphocytic, Acute, L10low40
Leukemia, Lymphocytic, Acute, L20low40
Leukemia, Lymphocytic, Acute, Mixed Cell0low10
Leukemia, Lymphocytic, Acute, Mixed-Cell0low10
Leukemia, Lymphoid0low70
Leukemia, Lymphoid, Acute0low40
Leukemia, Mixed-Cell0low10
Leukemia, Mixed, B and T Cell0low10
Leukemia, Mixed, B- and T-Cell0low10
Leukemia, Monocytic, Chronic0medium41
Leukemia, Myeloblastic, Acute0low120
Leukemia, Myelocytic0medium41
Leukemia, Myelocytic, Acute0low120
Leukemia, Myelocytic, Chronic0low10
Leukemia, Myelogenous0medium41
Leukemia, Myelogenous, Acute0low120
Leukemia, Myelogenous, Chronic0low10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive0low10
Leukemia, Myelogenous, Ph1 Positive0low10
Leukemia, Myelogenous, Ph1-Positive0low10
Leukemia, Myeloid0medium41
Leukemia, Myeloid, Acute0low120
Leukemia, Myeloid, Acute, M10low120
Leukemia, Myeloid, Acute, M20low120
Leukemia, Myeloid, Acute, M30low30
Leukemia, Myeloid, Chronic0low10
Leukemia, Myeloid, Ph1 Positive0low10
Leukemia, Myeloid, Ph1-Positive0low10
Leukemia, Myeloid, Philadelphia Positive0low10
Leukemia, Myeloid, Philadelphia-Positive0low10
Leukemia, Nonlymphoblastic, Acute0low120
Leukemia, Nonlymphocytic, Acute0low120
Leukemia, Progranulocytic0low30
Leukemia, Promyelocytic, Acute0low30
Leukocytopenia0low10
Leukopenia0low10
Lipidoses0low10
Lipidosis0low10
Lipoidosis0low10
Liposarcoma0low10
Liposarcoma, Dedifferentiated0low10
Liposarcoma, Pleomorphic0low10
Liposarcoma, Well Differentiated0low10
Lung Diseases0low10
Lymph Node Metastasis0low10
Lymphatic Metastasis0low10
Lymphoblastic Leukemia0low40
Lymphoblastic Leukemia, Acute0low40
Lymphoblastic Leukemia, Acute, Adult0low40
Lymphoblastic Leukemia, Acute, Childhood0low40
Lymphoblastic Leukemia, Acute, L10low40
Lymphoblastic Leukemia, Acute, L20low40
Lymphoblastic Lymphoma0low40
Lymphocytic Leukemia0low70
Lymphocytic Leukemia, Acute0low40
Lymphocytic Leukemia, Acute, B and T Cell0low10
Lymphocytic Leukemia, Acute, B- and T-Cell0low10
Lymphocytic Leukemia, L10low40
Lymphocytic Leukemia, L20low40
Lymphoid Leukemia0low70
Lymphoma0low10
Lymphoma, Lymphoblastic0low40
Lymphoma, Malignant0low10
M3 ANLL0low30
Malignancy0low10
Malignant Glioma0low20
Malignant Neoplasms0low10
Metachronous Neoplasms0low10
Metachronous Second Primary Neoplasms0low10
Microcalcification0low10
Microcalcinosis0low10
Microsomal Triglyceride Transfer Protein Deficiency0low10
Microsomal Triglyceride Transfer Protein Deficiency Disease0low10
Mixed Glioma0low20
Mixed-Lineage Acute Leukemias0low10
Moniliasis0low10
Monocytic Leukemia, Chronic0medium41
Muir-Torre Syndrome0low10
Muscle Disorders0low10
Muscular Diseases0low10
Myeloblastic Leukemia, Acute0low120
Myelocytic Leukemia0medium41
Myelocytic Leukemia, Acute0low120
Myelocytic Leukemia, Chronic0low10
Myelogenous Leukemia0medium41
Myelogenous Leukemia, Acute0low120
Myelogenous Leukemia, Chronic0low10
Myelogenous Leukemia, Ph1-Positive0low10
Myeloid Leukemia0medium41
Myeloid Leukemia, Acute0low120
Myeloid Leukemia, Acute, M10low120
Myeloid Leukemia, Acute, M20low120
Myeloid Leukemia, Acute, M30low30
Myeloid Leukemia, Chronic0low10
Myeloid Leukemia, Ph1-Positive0low10
Myeloid Leukemia, Philadelphia-Positive0low10
Myocardial Infarct0low10
Myocardial Infarction0low10
Myopathic Conditions0low10
Myopathies0low10
Necrosis0low10
Neoplasia0low10
Neoplasm0low10
Neoplasms0low10
Neoplasms, Benign0low10
Neoplasms, Experimental0low10
Neoplasms, Laryngeal0low10
Neoplasms, Metachronous0low10
Neoplasms, Metachronous Second Primary0low10
Neoplasms, Sebaceous Gland0low10
Neoplasms, Second Primary0low10
Neoplasms, Therapy-Associated0low10
Neoplasms, Therapy-Related0low10
Neoplasms, Treatment-Associated0low10
Neoplasms, Treatment-Related0low10
Neoplastic Cell Transformation0low10
Neoplastic Transformation, Cell0low10
Neuropathy of Tangier Disease0low10
Nonlymphoblastic Leukemia, Acute0low120
Nonlymphocytic Leukemia, Acute0low120
Obesity0low10
Oculocutaneous Albinism with Leukocyte Defect0low10
Odontogenic Cysts0low10
Omenn Syndrome0low10
Omenn's Syndrome0low10
Ossification, Ectopic0low10
Ossification, Heterotopic0low10
Ossification, Pathologic0low10
Ossification, Pathological0low10
Palatal Neoplasms0low10
Pathologic Calcification0low10
Pathologic Ossification0low10
Posterior Circulation Transient Ischemic Attack0low10
Precursor Cell Lymphoblastic Leukemia-Lymphoma0low40
Pregnancy0low20
Progranulocytic Leukemia0low30
Promyelocytic Leukemia, Acute0low30
Pulmonary Disease0low10
Pulmonary Diseases0low10
Rachitis0low20
Reticuloendotheliosis, Familial0low10
Reticulolymphosarcoma0low10
Retinal Drusen0low10
Rheumatoid Arthritis0low10
Rickets0low20
Sarcoma, Germinoblastic0low10
Sebaceous Gland Neoplasms0low10
Second Cancer0low10
Second Malignancy0low10
Second Neoplasm0low10
Second Primary Neoplasms0low10
Second Primary Neoplasms, Metachronous0low10
Sensitivity and Specificity0low30
Severe Combined Immune Deficiency0low10
Severe Combined Immunodeficiency0low10
Severe Combined Immunodeficiency Syndrome0low10
Severe Combined Immunologic Deficiency0low10
Smear Layer0medium11
Soft Tissue Neoplasms0low10
Steatitis0low10
Subarachnoid Hemorrhagic Stroke0low10
Susceptibility, Disease0low10
Swine Diseases0low10
Taenia brauni Infection0low10
Taenia glomeratus Infection0low10
Taenia Infections0low10
Taenia multiceps Infection0low10
Taenia serialis Infection0low10
Taenia solium Infection0low10
Taeniasis0low10
Tangier Disease0low10
Tangier Disease Neuropathy0low10
Tangier Hereditary Neuropathy0low10
TBI (Traumatic Brain Injury)0low10
TBIs (Traumatic Brain Injuries)0low10
Therapy-Associated Cancer0low10
Therapy-Associated Neoplasms0low10
Therapy-Related Cancer0low10
Therapy-Related Neoplasms0low10
Thyroid Diseases0low10
TIA (Transient Ischemic Attack)0low10
Transformation, Neoplastic Cell0low10
Transient Ischemic Attack0low10
Transient Ischemic Attack, Anterior Circulation0low10
Transient Ischemic Attack, Brain Stem0low10
Transient Ischemic Attack, Brainstem0low10
Transient Ischemic Attack, Carotid Circulation0low10
Transient Ischemic Attack, Posterior Circulation0low10
Transient Ischemic Attack, Vertebrobasilar Circulation0low10
Transient Ischemic Attacks, Crescendo0low10
Trauma, Brain0low10
Traumatic Brain Injury0low10
Traumatic Encephalopathy0low10
Treatment-Associated Cancer0low10
Treatment-Associated Neoplasms0low10
Treatment-Related Cancer0low10
Treatment-Related Neoplasms0low10
Tumorigenic Transformation0low10
Tumors0low10
Vascular Diseases0low10
Vertebrobasilar Circulation Transient Ischemic Attack0low10
Wake-up Stroke0low10
Wallerian Degeneration0low10
Well Differentiated Liposarcoma0low10

Research Highlights

Dosage (1)

ArticleYear
The importance of the diluent for airway transport of toluene diisocyanate following intranasal dosing of mice.
Inhalation toxicology, Volume: 11, Issue: 3		1999
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]